Healthcare · NSE: THYROCARE
Thyrocare Technologies Limited
₹494.50
+0.26% · close 28 Oct 2026
Prices before 28 Nov 2025 are adjusted for a split, bonus or consolidation.
52-week range
₹349.55 – ₹649.35
From 52W high
-23.85%
Return 1Y
+11.52%
Volume · Avg 20D
4.43 L · 3.46 L
Returns & technicals
1W+8.40%
1M-12.76%
3M-14.70%
6M+19.89%
1Y+11.52%
| 50-day average | ₹544.87 below |
| 200-day average | ₹486.23 above |
| Volatility (1Y, annualised) | 40.03% |
| RSI (14) | 44.3 |
| MACD histogram (12, 26, 9) | 1.63 |
| Delivery · 20D avg | 54.55% · 53.79% |
| Turnover (last day) | ₹22 Cr |
Profile
| Symbol | THYROCARE |
| ISIN | INE594H01019 |
| Sector | Healthcare |
| Listed on NSE | 9 May 2016 |
| Face value | ₹10 |
| Series | EQ |
Financials & shareholding
Quarterly results, P/E and the shareholding pattern for THYROCARE are coming in a later update.
Peers in Healthcare
| Stock | Price | Day | 1M | 1Y |
|---|---|---|---|---|
| PPLPHARMA Piramal Pharma Limited | ₹232.80 | +17.15% | +10.69% | +15.19% |
| SYNGENE Syngene International Limited | ₹410.85 | +12.19% | +8.49% | -37.51% |
| ACUTAAS Acutaas Chemicals Limited | ₹3,710.00 | -2.20% | +13.37% | +116.38% |
| DIVISLAB Divi's Laboratories Limited | ₹9,558.50 | +0.56% | -0.63% | +48.46% |
| ONESOURCE Onesource Specialty Pharma Limited | ₹1,577.60 | -0.77% | -1.56% | -14.00% |
| APOLLOHOSP Apollo Hospitals Enterprise Limited | ₹8,137.00 | +4.43% | -8.46% | +3.25% |